ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 998,02
0,06%
Dow Jones
38 292,54
-1,02%
DAX
18 608,16
0,68%
Brent Oil
78,405
-2,97%
Bitcoin
69 163,59
2,09%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vernalis Plc ADS (MM) (VNLS)

  7. Vernalis Plc ADS (MM) (VNLS) Actualités

VNLS

Vernalis (VNLS)

Vernalis Plc ADS (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VNLS
DateHeureSourceTitreSymboleSociété
11/12/200608h00PR Newswire (US)Vernalis plc Initiates a Phase I Trial of a Promising New Approach to Treating Obesity and Related Disorders - Including Type IINASDAQ:VNLS
21/11/200608h00PR Newswire (US)Vernalis plc to Present at the 18th Annual Piper Jaffray Healthcare Conference in New York on November 30, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
20/11/200608h00PR Newswire (US)Vernalis plc Announces Progress on Its Oncology Hsp90 ProgrammeNASDAQ:VNLS
02/11/200608h00PR Newswire (US)Vernalis to Present at Cowen and Company 7th Annual Global Health Care ConferenceNASDAQ:VNLS
20/09/200615h31PR Newswire (US)Vernalis plc to Present at UBS Global Life Sciences Conference on September 26, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
20/09/200612h30PR Newswire (US)Vernalis plc Announces FDA Acceptance for Filing of Frova(R) for Short-Term Prevention of Menstrual MigraineNASDAQ:VNLS
12/09/200609h00PR Newswire (US)Vernalis Plc: Interim Results for the Six Months Ended 30 June 2006NASDAQ:VNLS
20/07/200600h00PR Newswire (US)Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of MenNASDAQ:VNLSVernalis Plc ADS (MM)
19/06/200613h00PR Newswire (US)Vernalis plc to Present at Investor Conferences During June 2006NASDAQ:VNLSVernalis Plc ADS (MM)
17/05/200619h00PR Newswire (US)Vernalis plc [VNLS] CEO to Ring the NASDAQ Stock Market Closing BellNASDAQ:VNLSVernalis Plc ADS (MM)
15/05/200609h00PR Newswire (US)Vernalis plc to Ring the NASDAQ Closing Bell on May 18, 2006NASDAQ:VNLS
08/05/200609h00PR Newswire (US)Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual MigraineNASDAQ:VNLS
15/07/200400h50PR Newswire (US)Endo Licenses Rights from Vernalis to Market Acute Migraine Treatment Frova(TM)NASDAQ:VNLS
30/03/200414h00PR Newswire (US)Vernalis Regains Control of North American Rights To Frovatriptan From ElanNASDAQ:VNLSVernalis Plc ADS (MM)
30/03/200414h00PR Newswire (US)Vernalis plc: Preliminary Results for the Eight Months Ended 31 December 2003NASDAQ:VNLS
 Showing the most relevant articles for your search:NASDAQ:VNLS

Dernières Valeurs Consultées

NYSE
GSQB.U
G Squared Ascend II
AMEX
REGL
ProShares S&P MidCap 400...
TG
0AQA
Annington
ASX
JATDE
Jatcorp
BIT
EMV
Exchange Traded
BIT
UC0462
Unicredit Bank
LSE
JB65
Citi Fun 25
BIT
P18965
BNP Paribas Issuance
EU
FEBLB
Fromageries Bel SA 1.5% ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés